The relationship between payer type and lipid outcomes in response to clinical lifestyle interventions in youth with dyslipidemia
Abstract Background Payer-type (government-sponsored health coverage versus private health insurance) has been shown to influence a variety of cardiovascular disease outcomes in adults. However, it is unclear if the payer-type impacts the response to a lifestyle intervention in children with dyslipi...
Saved in:
Main Authors: | Jacob C. Hartz (Author), Elizabeth Yellen (Author), Annette Baker (Author), Justin Zachariah (Author), Heather Ryan (Author), S. Skylar Griggs (Author), Nirav K Desai (Author), Ravi Yanumula (Author), Samuel Vinci (Author), Caroline Brantley (Author), Jennifer Bachman (Author), Ellen McAuliffe (Author), Kimberlee Gauvreau (Author), Michael Mendelson (Author), Sarah de Ferranti (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An integrated valuation model for payer and investor
by: Mark Nuijten, et al.
Published: (2022) -
Are payers treating orphan drugs differently?
by: Joshua P. Cohen, et al.
Published: (2014) -
Patient and Payer Preferences for Additional Value Criteria
by: Ivett Jakab, et al.
Published: (2021) -
Screening and socioeconomic associations of dyslipidemia in young adults
by: Stephen E. Hudson, et al.
Published: (2020) -
Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
by: Epstein RS
Published: (2021)